Inactivation of RB1 and histological transformation in EGFR-mutant lung adenocarcinoma.

Zhai, H; Moore, D; Jamal-Hanjani, M

Zhai, H; Moore, D; Jamal-Hanjani, M.

Afiliação

Zhai H; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Moore D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Pathology, University College London Hospitals NHS Foundation Trust, London, UK.
Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: m.jamal-hanjani@ucl.ac.uk.

Ann Oncol ; 31(2): 169-170, 2020 02.

Article em En | MEDLINE | ID: mdl-31959334

Assuntos

Adenocarcinoma de Pulmão; Neoplasias Pulmonares; Receptores ErbB; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google